Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages

Chronic lymphocytic leukemia (CLL) has a variable clinical evolution, with some patients living treatment-free for decades while others require therapy shortly after diagnosis. In a consecutive series of 217 CLL patients, molecular biomarkers with prognostic value (IGHV status, TP53 mutations, and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Suárez-Cabrera, Alexia, Fiallo-Suárez, Dolly Viviana, Stuckey, Ruth, Uroz-de la Iglesia, Marta Luna, Florido, Yanira, Lemes-Castellano, Angelina, Perera-Álvarez, Miguel Ángel, Luzardo-Henríquez, Hugo, de la Nuez, Haridian, Fernández-Caldas, Paula, de la Iglesia, Silvia, Gómez-Casares, María Teresa, Bilbao-Sieyro, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394282/
https://www.ncbi.nlm.nih.gov/pubmed/35892513
http://dx.doi.org/10.3390/diagnostics12081802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394282/
https://www.ncbi.nlm.nih.gov/pubmed/35892513
http://dx.doi.org/10.3390/diagnostics12081802

Ejemplares similares